Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Glycoprotein 130

From Wikipedia, the free encyclopedia
Mammalian protein found in Homo sapiens
This article is about the glycoprotein. For the stimulant drug, seeG-130.
"Cd130" redirects here. For the isotope of cadmium (Cd-130 or130Cd), seeCadmium-130.

IL6ST
Available structures
PDBOrtholog search:PDBeRCSB
List of PDB id codes

1BJ8,1BQU,1I1R,1P9M,1PVH,3L5H,3L5I,3L5J,%%s1BJ8,1BQU,1I1R,1P9M,1PVH,3L5H,3L5I,3L5J,1N2Q

Identifiers
AliasesIL6ST, CD130, CDW130, GP130, IL-6RB, interleukin 6 signal transducer
External IDsOMIM:600694;MGI:96560;HomoloGene:1645;GeneCards:IL6ST;OMA:IL6ST - orthologs
Gene location (Human)
Chromosome 5 (human)
Chr.Chromosome 5 (human)[1]
Chromosome 5 (human)
Genomic location for IL6ST
Genomic location for IL6ST
Band5q11.2Start55,935,095bp[1]
End55,994,993bp[1]
Gene location (Mouse)
Chromosome 13 (mouse)
Chr.Chromosome 13 (mouse)[2]
Chromosome 13 (mouse)
Genomic location for IL6ST
Genomic location for IL6ST
Band13 D2.2|13 63.73 cMStart112,600,604bp[2]
End112,646,620bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • parietal pleura

  • germinal epithelium

  • visceral pleura

  • seminal vesicula

  • caput epididymis

  • tail of epididymis

  • superficial temporal artery

  • pericardium

  • lactiferous duct

  • lower lobe of lung
Top expressed in
  • decidua

  • skin of external ear

  • uterus

  • mesenteric lymph nodes

  • right lung

  • right lung lobe

  • gastrula

  • carotid body

  • urinary bladder

  • cardiac muscle tissue of left ventricle
More reference expression data
BioGPS
n/a
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo /QuickGO
Orthologs
SpeciesHumanMouse
Entrez

3572

16195

Ensembl

ENSG00000134352

ENSMUSG00000021756

UniProt

P40189
Q17RA0

Q00560

RefSeq (mRNA)

NM_001190981
NM_002184
NM_175767

NM_010560

RefSeq (protein)
NP_001177910
NP_002175
NP_786943
NP_001351204
NP_001351205

NP_001351206
NP_001351207
NP_001351208
NP_002175.2
NP_001177910.1

NP_034690

Location (UCSC)Chr 5: 55.94 – 55.99 MbChr 13: 112.6 – 112.65 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Glycoprotein 130 (also known asgp130,IL6ST,IL6R-beta orCD130) is atransmembrane protein which is the founding member of the class of tallcytokine receptors. It forms onesubunit of thetype I cytokine receptor within theIL-6 receptor family. It is often referred to as the common gp130 subunit, and is important forsignal transduction followingcytokine engagement. As with other type I cytokine receptors, gp130 possesses a WSXWSamino acid motif that ensures correctprotein folding andligand binding. It interacts withJanus kinases to elicit anintracellular signal following receptor interaction with its ligand. Structurally, gp130 is composed of fivefibronectin type-IIIdomains and oneimmunoglobulin-like C2-type (immunoglobulin-like) domain in its extracellular portion.[5][6]

Characteristics

[edit]

The members of theIL-6 receptor family are all complex with gp130 for signal transduction. For example, IL-6 binds to the IL-6 Receptor. The complex of these two proteins then associates with gp130. This complex of 3 proteins thenhomodimerizes to form ahexameric complex which can produce downstream signals.[7] There are many other proteins which associate with gp130, such ascardiotrophin 1 (CT-1),leukemia inhibitory factor (LIF),ciliary neurotrophic factor (CNTF),oncostatin M (OSM), andIL-11.[8] There are also several other proteins which have structural similarity to gp130 and contain the WSXWS motif and preserved cysteine residues. Members of this group includeLIF-R,OSM-R, andG-CSF-R.

Inhibition of gp130

[edit]

gp130 is an important part of many different types of signaling complexes. Inactivation of gp130 during development is lethal to mice.[9]Homozygous mice who are born show a number of defects including impaired development of theventricularmyocardium.Haematopoietic effects included reduced numbers ofstem cells in thespleen andliver. Loss of gp130 in the adult mouse, either globally or in a tissue-specific manner, is however increasingly linked with beneficial effects in a number of mouse models of disease.[10] Of note, soluble gp130 (sgp130), which was thought a specific inhibitor of IL6 trans signalling, was instead found to inhibit not only IL6 signalling but also multiple other IL6-family cytokines (e.g. OSM, IL11 and CNTF).[10] Thus the widespread benefits of sgp130 in mouse models,[11] and in human trials,[12] may represent the benefits of global (or near global) inhibition of gp130. This suggests gp130 itself as a therapeutic target for human diseases including sepsis, systemic sclerosis, inflammatory bowel disease, among others.

Signal transduction

[edit]

gp130 has no intrinsictyrosine kinase activity. Instead, it isphosphorylated ontyrosine residues aftercomplexing with otherproteins. The phosphorylation leads to association withJAK/Tyk tyrosine kinases andSTAT proteintranscription factors.[13] In particular,STAT-3 is activated which leads to the activation of many downstream genes. Other pathways activated includeRAS andMAPK signaling.

Interactions

[edit]

Glycoprotein 130 has been shown tointeract with:

References

[edit]
  1. ^abcGRCh38: Ensembl release 89: ENSG00000134352Ensembl, May 2017
  2. ^abcGRCm38: Ensembl release 89: ENSMUSG00000021756Ensembl, May 2017
  3. ^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^"Mouse PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T (Dec 1990). "Molecular cloning and expression of an IL-6 signal transducer, gp130".Cell.63 (6):1149–1157.doi:10.1016/0092-8674(90)90411-7.PMID 2261637.S2CID 30852638.
  6. ^Bravo J, Staunton D, Heath JK, Jones EY (Mar 1998)."Crystal structure of a cytokine-binding region of gp130".The EMBO Journal.17 (6):1665–1674.doi:10.1093/emboj/17.6.1665.PMC 1170514.PMID 9501088.
  7. ^Murakami M, Hibi M, Nakagawa N, Nakagawa T, Yasukawa K, Yamanishi K, et al. (Jun 1993). "IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase".Science.260 (5115). New York, N.Y.:1808–1810.Bibcode:1993Sci...260.1808M.doi:10.1126/science.8511589.PMID 8511589.
  8. ^Kishimoto T, Akira S, Narazaki M, Taga T (Aug 1995)."Interleukin-6 family of cytokines and gp130".Blood.86 (4):1243–1254.doi:10.1182/blood.V86.4.1243.bloodjournal8641243.PMID 7632928.
  9. ^Yoshida K, Taga T, Saito M, Suematsu S, Kumanogoh A, Tanaka T, et al. (Jan 1996)."Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders".Proceedings of the National Academy of Sciences of the United States of America.93 (1):407–411.Bibcode:1996PNAS...93..407Y.doi:10.1073/pnas.93.1.407.PMC 40247.PMID 8552649.
  10. ^abWidjaja AA, Cook SA (2024-01-23)."Nonspecific Inhibition of IL6 Family Cytokine Signalling by Soluble gp130".International Journal of Molecular Sciences.25 (3): 1363.doi:10.3390/ijms25031363.ISSN 1422-0067.PMC 10855816.PMID 38338642.
  11. ^Rose-John S, Jenkins BJ, Garbers C, Moll JM, Scheller J (October 2023)."Targeting IL-6 trans-signalling: past, present and future prospects".Nature Reviews. Immunology.23 (10):666–681.doi:10.1038/s41577-023-00856-y.ISSN 1474-1733.PMC 10108826.PMID 37069261.
  12. ^Zhang S, Chen B, Wang B, Chen H, Li Y, Cao Q, et al. (2023-03-07)."Effect of Induction Therapy With Olamkicept vs Placebo on Clinical Response in Patients With Active Ulcerative Colitis: A Randomized Clinical Trial".JAMA.329 (9):725–734.doi:10.1001/jama.2023.1084.ISSN 0098-7484.PMC 9993185.PMID 36881032.
  13. ^Kishimoto T, Taga T, Akira S (Jan 1994). "Cytokine signal transduction".Cell.76 (2):253–262.doi:10.1016/0092-8674(94)90333-6.PMID 8293462.S2CID 31924790.
  14. ^Lee IS, Liu Y, Narazaki M, Hibi M, Kishimoto T, Taga T (January 1997)."Vav is associated with signal transducing molecules gp130, Grb2 and Erk2, and is tyrosine phosphorylated in response to interleukin-6".FEBS Letters.401 (2–3):133–137.Bibcode:1997FEBSL.401..133L.doi:10.1016/s0014-5793(96)01456-1.PMID 9013873.S2CID 32632406.
  15. ^Grant SL, Hammacher A, Douglas AM, Goss GA, Mansfield RK, Heath JK, et al. (January 2002). "An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells".Oncogene.21 (3):460–474.doi:10.1038/sj.onc.1205100.PMID 11821958.S2CID 19754641.
  16. ^abKim H, Baumann H (December 1997)."Transmembrane domain of gp130 contributes to intracellular signal transduction in hepatic cells".Journal of Biological Chemistry.272 (49):30741–30747.doi:10.1074/jbc.272.49.30741.PMID 9388212.
  17. ^Haan C, Is'harc H, Hermanns HM, Schmitz-Van De Leur H, Kerr IM, Heinrich PC, et al. (October 2001)."Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction".Journal of Biological Chemistry.276 (40):37451–37458.doi:10.1074/jbc.M106135200.PMID 11468294.
  18. ^Haan C, Heinrich PC, Behrmann I (January 2002)."Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation".The Biochemical Journal.361 (Pt 1):105–111.doi:10.1042/0264-6021:3610105.PMC 1222284.PMID 11742534.
  19. ^Timmermann A, Küster A, Kurth I, Heinrich PC, Müller-Newen G (June 2002). "A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor".European Journal of Biochemistry.269 (11):2716–2726.doi:10.1046/j.1432-1033.2002.02941.x.PMID 12047380.
  20. ^Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS, et al. (December 1996)."Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation".Journal of Biological Chemistry.271 (51):32635–32643.doi:10.1074/jbc.271.51.32635.PMID 8999038.
  21. ^abLehmann U, Schmitz J, Weissenbach M, Sobota RM, Hortner M, Friederichs K, et al. (January 2003)."SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130".Journal of Biological Chemistry.278 (1):661–671.doi:10.1074/jbc.M210552200.PMID 12403768.
  22. ^Anhuf D, Weissenbach M, Schmitz J, Sobota R, Hermanns HM, Radtke S, et al. (September 2000)."Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation".Journal of Immunology.165 (5). Baltimore, Md.:2535–2543.doi:10.4049/jimmunol.165.5.2535.PMID 10946280.
  23. ^Giordano V, De Falco G, Chiari R, Quinto I, Pelicci PG, Bartholomew L, et al. (May 1997)."Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase".Journal of Immunology.158 (9). Baltimore, Md.:4097–4103.doi:10.4049/jimmunol.158.9.4097.PMID 9126968.S2CID 44339682.
  24. ^Liu F, Liu Y, Li D, Zhu Y, Ouyang W, Xie X, et al. (March 2002). "The transcription co-repressor TLE1 interacted with the intracellular region of gpl30 through its Q domain".Molecular and Cellular Biochemistry.232 (1–2):163–167.doi:10.1023/A:1014880813692.PMID 12030375.S2CID 8270300.

Further reading

[edit]

External links

[edit]
PDB gallery
  • 1bj8: THIRD N-TERMINAL DOMAIN OF GP130, NMR, MINIMIZED AVERAGE STRUCTURE
    1bj8: THIRD N-TERMINAL DOMAIN OF GP130, NMR, MINIMIZED AVERAGE STRUCTURE
  • 1bqu: CYTOKYNE-BINDING REGION OF GP130
    1bqu: CYTOKYNE-BINDING REGION OF GP130
  • 1i1r: CRYSTAL STRUCTURE OF A CYTOKINE/RECEPTOR COMPLEX
    1i1r: CRYSTAL STRUCTURE OF A CYTOKINE/RECEPTOR COMPLEX
  • 1p9m: Crystal structure of the hexameric human IL-6/IL-6 alpha receptor/gp130 complex
    1p9m: Crystal structure of the hexameric human IL-6/IL-6 alpha receptor/gp130 complex
  • 1pvh: Crystal structure of leukemia inhibitory factor in complex with gp130
    1pvh: Crystal structure of leukemia inhibitory factor in complex with gp130
1–50
51–100
101–150
151–200
201–250
251–300
301–350
Chemokine receptor
(GPCRs)
CC
CXC
Other
TNF receptor
1-10
11-20
21-27
JAK-STAT
Type I
γ-chain
β-chain
gp130
IL12RB1
Other
Type II
Ig superfamily
IL 17 family
Enzyme-linked receptor
Chemokine
CSF
Erythropoietin
G-CSF (CSF3)
GM-CSF (CSF2)
M-CSF (CSF1)
SCF (c-Kit)
Thrombopoietin
Interferon
IFNAR (α/β, I)
IFNGR (γ, II)
IFNLR (λ, III)
  • See IL-28R (IFNLR)here instead.
Interleukin
TGFβ
TNF
Others
JAK
(inhibitors)
JAK1
JAK2
JAK3
TYK2
Others
IL-1
IL-2
IL-3
IL-4
IL-5
IL-6
IL-7
IL-8
  • See CXCR1 (IL-8Rα) and CXCR2 (IL-8Rβ)here instead.
IL-9
IL-10
IL-11
IL-12
IL-13
IL-15
IL-17
IL-18
IL-20
IL-21
IL-22
IL-23
IL-27
IL-28
IL-31
IL1RL1
IL1RL2
Others
JAK
Others
Retrieved from "https://en.wikipedia.org/w/index.php?title=Glycoprotein_130&oldid=1296629171"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp